RegulatoryThe Sayre team comes with a demonstrated track record of novel product registrations in the Indian sub-continent. Sayre will work with health authorities in South Asia to build the regulatory pathway for our Licensors, including local clinical trials or post-marketing studies to facilitate and secure registrations for our portfolio of novel drugs, drug-delivery devices and companion diagnostics.